Department of Urology, Global Hospital, Dr E Borges Road, Parel, Mumbai, 400012, India.
World J Urol. 2018 Apr;36(4):537-541. doi: 10.1007/s00345-018-2213-y. Epub 2018 Feb 9.
For the last 20 years, the predominant robot used in laparoscopic surgery has been Da Vinci by Intuitive Surgical. This monopoly situation has led to rising costs and relatively slow innovation. This article aims to discuss the two new robotic devices for laparoscopic surgery which have received regulatory approval for human use in different parts of the world.
A short description of the Senhance Surgical Robotic System and the REVO-I Robot Platform and their pros and cons compared to the Da Vinci system is presented. A discussion about the differences between the three robotic systems now in the market is presented, as well as a short review of the present state of robotic assistance in surgery and where we are headed.
在过去的 20 年中,腹腔镜手术中使用的主要机器人是直觉外科公司的达芬奇机器人。这种垄断局面导致了成本的上升和相对缓慢的创新。本文旨在讨论两种新的腹腔镜手术机器人设备,它们已在世界不同地区获得了用于人体的监管批准。
本文简短描述了 Senhance 手术机器人系统和 REVO-I 机器人平台,以及它们与达芬奇系统相比的优缺点。本文还讨论了目前市场上三种机器人系统之间的差异,以及对手术机器人辅助的现状和未来发展方向的简要回顾。